According to Ke Zhou et al., nuclear enriched abundant transcript 1 (NEAT1) silencing inhibits motility and invasion of glioma cells by modifying SRY-Box Transcription Factor 2 (SOX2), which miR-132 targets. Here, NEAT1 is linked to central nervous system cancer.